Analyst consensus rating
OrthoPediatrics Analyst Rating: none
Direct answer
OrthoPediatrics's consensus rating is none.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $27.22.
Forecast evidence checked September 12, 2026.
Get free OrthoPediatrics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $22.06
- Average price target
- $27.22
- High price target
- $35.00
- Low price target
- $22.00
- Low target gap
- -0.3%
- Target upside
- +23.4%
- High target gap
- +58.7%
- Target range width
- 58.9%
- Consensus rating
- none
- Analysts
- 9
- Evidence date
- September 12, 2026
- Valid through
- September 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for OrthoPediatrics?
OrthoPediatrics has a verified none consensus. The same dataset has an average price target of $27.22.
How far are OrthoPediatrics's low and high targets from the recorded price?
The low target implies -0.3%, while the high target implies +58.7%.
How many analysts are included in OrthoPediatrics's consensus?
The verified consensus includes 9 analysts.
How is OrthoPediatrics's target upside or downside calculated?
The average target of $27.22 is divided by the recorded price of $22.06, then one is subtracted to produce +23.4%. This does not guarantee a future return.
When was OrthoPediatrics's analyst forecast verified?
The data was verified on 2026-09-12. The dataset is valid through 2026-09-19.